{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T08:08:30Z","timestamp":1793606910920,"version":"4.5.0"},"reference-count":26,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2020,3,1]],"date-time":"2020-03-01T00:00:00Z","timestamp":1583020800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,3,1]],"date-time":"2020-03-01T00:00:00Z","timestamp":1583020800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"nVision Medical"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","gynecologiconcology-online.net","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Gynecologic Oncology"],"published-print":{"date-parts":[[2020,3]]},"DOI":"10.1016\/j.ygyno.2019.12.026","type":"journal-article","created":{"date-parts":[[2020,1,7]],"date-time":"2020-01-07T08:11:48Z","timestamp":1578384708000},"page":"636-640","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"title":["Cytological sampling of fallopian tubes using a hysteroscopic catheter: A multi-center study"],"prefix":"10.1016","volume":"156","author":[{"given":"C. Bethan","family":"Powell","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ramey D.","family":"Littell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"Jr.","given":"Charles N.","family":"Landen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sharmila","family":"Pramanik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabella C.","family":"Hamilton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth J.","family":"Suh-Burgmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ygyno.2019.12.026_bb0005","first-page":"7","article-title":"Cancer statistics, 2019","volume":"69","author":"Siegel","year":"2019","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.ygyno.2019.12.026_bb0010","series-title":"SEER Cancer Statistics Review, 1975\u20132015","author":"Noone","year":"2018"},{"key":"10.1016\/j.ygyno.2019.12.026_bb0015","series-title":"NCCN Clinical Practice Guidelines in Oncology","article-title":"Genetic\/familial high-risk assessment: breast and ovarian","author":"NCCN","year":"2019"},{"key":"10.1016\/j.ygyno.2019.12.026_bb0020","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1001\/jama.2017.21926","article-title":"Screening for ovarian cancer: US preventive services task force recommendation statement","volume":"319","author":"US Preventive Services Task Force","year":"2018","journal-title":"JAMA"},{"key":"10.1016\/j.ygyno.2019.12.026_bb0025","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1097\/AOG.0000000000002289","article-title":"Committee opinion no. 716 summary: the role of the obstetrician-gynecologist in the early detection of epithelial ovarian cancer in women at average risk","volume":"130","year":"2017","journal-title":"Obstet. Gynecol."},{"key":"10.1016\/j.ygyno.2019.12.026_bb0030","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.ygyno.2010.06.003","article-title":"SGO White Paper on ovarian cancer: etiology, screening and surveillance","volume":"119","author":"Schorge","year":"2010","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2019.12.026_bb0035","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1002\/path.2091","article-title":"A candidate precursor to serous carcinoma that originates in the distal fallopian tube","volume":"211","author":"Lee","year":"2007","journal-title":"J. Pathol."},{"key":"10.1016\/j.ygyno.2019.12.026_bb0040","doi-asserted-by":"crossref","first-page":"4160","DOI":"10.1200\/JCO.2008.16.4814","article-title":"Serous tubal intraepithelial carcinoma: its potential role in primary peritoneal serous carcinoma and serous cancer prevention","volume":"26","author":"Carlson","year":"2008","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.ygyno.2019.12.026_bb0045","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1097\/PAS.0b013e3181cf3d79","article-title":"The origin and pathogenesis of epithelial ovarian cancer: a proposed unifying theory","volume":"34","author":"Kurman","year":"2010","journal-title":"Am. J. Surg. Pathol."},{"key":"10.1016\/j.ygyno.2019.12.026_bb0050","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/1756-8722-5-8","article-title":"Ovarian serous carcinoma: recent concepts on its origin and carcinogenesis","volume":"5","author":"Li","year":"2012","journal-title":"J. Hematol. Oncol."},{"key":"10.1016\/j.ygyno.2019.12.026_bb0055","first-page":"182","article-title":"Fallopian tube as main source for ovarian and pelvic (non-endometrial) serous carcinomas","volume":"5","author":"Zheng","year":"2012","journal-title":"Int. J. Clin. Exp. Pathol."},{"key":"10.1016\/j.ygyno.2019.12.026_bb0060","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/j.ajog.2013.04.019","article-title":"The role of the fallopian tube in the origin of ovarian cancer","volume":"209","author":"Erickson","year":"2013","journal-title":"Am. J. Obstet. Gynecol."},{"key":"10.1016\/j.ygyno.2019.12.026_bb0065","doi-asserted-by":"crossref","first-page":"108","DOI":"10.3389\/fonc.2016.00108","article-title":"Ovarian cancer: the fallopian tube as the site of origin and opportunities for prevention","volume":"6","author":"George","year":"2016","journal-title":"Front. Oncol."},{"key":"10.1016\/j.ygyno.2019.12.026_bb0070","doi-asserted-by":"crossref","first-page":"1488","DOI":"10.1038\/modpathol.2011.106","article-title":"Tubal origin of \u201covarian\u201d low-grade serous carcinoma","volume":"24","author":"Li","year":"2011","journal-title":"Mod. Pathol."},{"key":"10.1016\/j.ygyno.2019.12.026_bb0075","first-page":"13","article-title":"Tubal origin of ovarian low-grade serous carcinoma","volume":"1","author":"Chen","year":"2013","journal-title":"Am. J. Clin. Exp. Obstet. Gynecol."},{"key":"10.1016\/j.ygyno.2019.12.026_bb0080","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1111\/his.12046","article-title":"Fallopian tube precursors of ovarian low- and high-grade serous neoplasms","volume":"62","author":"Vang","year":"2013","journal-title":"Histopathology"},{"key":"10.1016\/j.ygyno.2019.12.026_bb0085","unstructured":"FDA, (n.d.) 510(k) summary. https:\/\/www.accessdata.fda.gov\/cdrh_docs\/pdf16\/K160510.pdf (accessed May 28, 2019)."},{"key":"10.1016\/j.ygyno.2019.12.026_bb0090","first-page":"1","article-title":"Hysteroscopic tubal sterilization: an evidence-based analysis","volume":"13","author":"McMartin","year":"2013","journal-title":"Ont. Health Technol. Assess. Ser."},{"key":"10.1016\/j.ygyno.2019.12.026_bb0095","unstructured":"Safety Communications, (n.d.). The FDA recommends against using screening tests for ovarian cancer screening: FDA safety communication. https:\/\/wayback.archive-it.org\/7993\/20171102225230\/https:\/\/www.fda.gov\/MedicalDevices\/Safety\/AlertsandNotices\/ucm519413.htm (accessed May 29, 2019)."},{"key":"10.1016\/j.ygyno.2019.12.026_bb0105","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1186\/s12935-016-0354-x","article-title":"Cytologic studies of the fallopian tube in patients undergoing salpingo-oophorectomy","volume":"16","author":"Chen","year":"2016","journal-title":"Cancer Cell Int."},{"key":"10.1016\/j.ygyno.2019.12.026_bb0110","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1159\/000353825","article-title":"Cytologic findings in experimental in vivo fallopian tube brush specimens","volume":"57","author":"Rodriguez","year":"2013","journal-title":"Acta Cytol."},{"key":"10.1016\/j.ygyno.2019.12.026_bb0115","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1016\/j.jmig.2014.03.017","article-title":"Brush cytology of the fallopian tube and implications in ovarian cancer screening","volume":"21","author":"Lum","year":"2014","journal-title":"J. Minim. Invasive Gynecol."},{"key":"10.1016\/j.ygyno.2019.12.026_bb0120","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1097\/PAP.0b013e3181b4fffa","article-title":"Ovarian low-grade and high-grade serous carcinoma: pathogenesis, clinicopathologic and molecular biologic features, and diagnostic problems","volume":"16","author":"Vang","year":"2009","journal-title":"Adv. Anat. Pathol."},{"key":"10.1016\/j.ygyno.2019.12.026_bb0125","doi-asserted-by":"crossref","first-page":"287","DOI":"10.3233\/CBM-2011-0167","article-title":"Molecular pathogenesis of endometrial and ovarian cancer","volume":"9","author":"Merritt","year":"2010","journal-title":"Cancer Biomark."},{"key":"10.1016\/j.ygyno.2019.12.026_bb0130","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1148\/rg.313105066","article-title":"Histologic, molecular, and cytogenetic features of ovarian cancers: implications for diagnosis and treatment","volume":"31","author":"Lalwani","year":"2011","journal-title":"Radiographics"},{"key":"10.1016\/j.ygyno.2019.12.026_bb0135","first-page":"EC08","article-title":"Diagnostic and prognostic significance of Ki-67 immunohistochemical expression in surface epithelial ovarian carcinoma","volume":"11","author":"Mahadevappa","year":"2017","journal-title":"J. Clin. Diagn. Res."}],"container-title":["Gynecologic Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825819318475?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825819318475?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T03:52:09Z","timestamp":1758772329000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090825819318475"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3]]},"references-count":26,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2020,3]]}},"alternative-id":["S0090825819318475"],"URL":"https:\/\/doi.org\/10.1016\/j.ygyno.2019.12.026","relation":{},"ISSN":["0090-8258"],"issn-type":[{"value":"0090-8258","type":"print"}],"subject":[],"published":{"date-parts":[[2020,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cytological sampling of fallopian tubes using a hysteroscopic catheter: A multi-center study","name":"articletitle","label":"Article Title"},{"value":"Gynecologic Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ygyno.2019.12.026","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}